Great article on $CRWG on #Cannabis! Cashing in on

New Post Public Reply Private Reply Replies (0) Message Board
langlui Lets Roll #2953
Great article on $CRWG on #Cannabis! Cashing in on Cannabis: CrowdGather's Smart Approach to Capturing Value From the Industry

REDONDO BEACH, CA / ACCESSWIRE / August 24, 2015 / The cannabis industry could reach $35 billion in size by 2020, according to GreenWave Advisors, while it's generally considered to be the fastest growing industry in the U.S. economy. While these dynamics should make the industry ripe for investment, the murky legality of industry on a federal level and the opaque nature of many existing publicly-traded companies in the space (that went public through reverse mergers) have made it treacherous for investors.

In this release, we'll take a look at CrowdGather's unique value proposition to investors interested in the cannabis industry.

Growing Institutional Interest

The cannabis industry has begun attracting significant levels of institutional interest. In January, venture capital heavyweight Peter Thiel announced that his $2 billion Founders Fund would be investing in Privateer Holdings, a marijuana company that owns several pot-related brands. The size of the investment wasn't officially disclosed, but insiders say that it was a "multimillion dollar" participation in Privateer's $75 million capital raise.

On a more granular level, ArcView Group has over 480 investor members that have invested over $45 million into 72 different companies. The group hosts webinars each week where up to five companies pitch investors, while offering large in-person events each quarter. With hundreds of high net worth individuals participating, the group has been an early pioneer in facilitating institutional level investments within the growing cannabis industry.

The common denominator is that these investments were all made in privately-held companies rather than publicly-traded companies. When it comes to traditional institutional investors - who may be limited to publicly-traded securities - there are fewer options. Many public companies have shaky finances, limited operating histories, and few disclosures when it comes to making regular filings with the Securities & Exchange Commission.

Ideal Risk-Free Exposure

CrowdGather operates a growing portfolio of special interest forums and scalable multi-platform games. In April, we announced the acquisition of digital assets including WeedTracker.com, DispensaryWeed.com, and WeedInHollywood.com as part of an effort to diversify its digital assets to capitalize on the growing cannabis industry. The diversification also is consistent with our overall focus of accumulating online users and monetizing them.

While companies like GW Pharmaceuticals plc (NASDAQ:GWPH) and Cannabis Science Inc. (CBIS) are pursuing clinical trials, our business model enables them to immediately capitalize on the information component of the growing industry without relying on regulatory approvals to begin realizing revenue by providing web services to cannabis consumers and then generating revenue from advertising.

We plan on building out WeedTracker.com into a fully-featured on-line cannabis community, while turning WeedInHollywood.com into its first cannabis themed gaming title. Beyond these efforts, our management hopes to become a nexus for the entire digital cannabis movement by designing a crowdfunding platform focused on cannabis that it intends to launch on its root domain - CrowdGather.com - in early 2016.

Our Business Model

Our social gaming business generated nearly $700,000 in revenue at a 75% gross margin during the three-months ended January 31, 2015, creating a base upon which to grow its newly acquired cannabis-focused businesses. Management believes the addition of high-growth cannabis opportunities on top of its existing business creates an opportunity for institutional and retail investors to get involved in the potential upside.

According to YCharts, the company's stock is trading more than 40% below its historical valuation of $0.0872, and we believe, below our enterprise value, and with an attractive price-book ratio. We believe these dynamics suggest that the stock may be undervalued based on its assets and historical valuations, despite the addition of its new gaming and cannabis-focused businesses that have the potential to create its opportunities.

The company's management has also been making changes to the cost structure aimed at improving profitability. In May of last year, the company sold off some of its legacy assets in order to shore up its balance sheet and raise cash. While platform fees and payroll costs have risen from its subsequent Plaor acquisition, we believe that ongoing revenue growth will offset and leverage these higher expenses as it achieves scale.

Looking Ahead

We believe CrowdGather offers an opportunity to capitalize on the rapidly growing cannabis industry without taking on any of the regulatory risk. In addition, the company has the added benefit of a rapidly growing gaming business and an equity that is trading at a compelling valuation. We hope Investors in the cannabis industry, including those involved with companies like Surna Inc. (SRNA) and MaryJane Group Inc. (MJMJ), may want to take a closer look at our stock.

During its last fiscal year, the company reported revenue that increased 51% to $2.4 million and a net loss ($7.1 million) on a per share basis that was cut in half from ($0.13) to ($0.06) per share. The majority of these results were realized from its social gaming division, which accounted for about three-quarters of revenue, while forum revenue accounted for much of the remainder. Management's daily bookings and other metrics have also been increasing.

As a vote of confidence in our future prospects, CrowdGather CEO Sanjay Sabnani has also been an active buyer of the stock in the open market, having purchased 50,000 shares in mid-June of this year at prices of $0.075 to $0.08 per share, according to Form 4 filings with the SEC. Additionally, Sabnani provided bridge financing to the company earlier this year of $270,000. These actions suggest that Mr. Sabnani remains confident in the company's future and believes that the current price of the stock may be undervalued.

To learn more, visit the company's website at www.crowdgather.com.

Read Full: http://finance.yahoo.com/news/cashing-cannabi...00557.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 302

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 377

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 180

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 464

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 322

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 360

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 405

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 80

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 182

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Prodigy Processing Solutions Leads the Charge in Cannabis Extraction

Updated Category News Views 240

Prodigy Processing Solutions Steps into New York's Cannabis Scene Prodigy Processing Solutions is making strides in the cannabis industry by teaming up with ProXtracts Processing Inc., a leading cannabis oil producer, to initiate a pioneering hydrocarbon extraction lab. This collaboration highlights Prodigy's commitment to providing top-notch extraction technologies while...

Continue Reading
Key Details for Moderna Investors Regarding Class Action

Updated Category News Views 69

Important Information for Moderna, Inc. Investors The Gross Law Firm has an important update for shareholders of Moderna, Inc. (NASDAQ: MRNA). If you've purchased shares during the specific class period, you're encouraged to reach out to the firm about possibly serving as lead plaintiffs in an upcoming class action lawsuit. Class Period and Lead Plaintiff Information If...

Continue Reading
Vistagen Therapeutics Investors: Important Legal Update Ahead

Updated Category News Views 117

Vistagen Therapeutics' Legal Challenges: A Summary for Investors As a prominent player in the therapeutic landscape, Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is currently navigating significant legal challenges that investors should be aware of. Legal representation is crucial for those who have invested in the company's stock, particularly following the announcement of...

Continue Reading
Nilfisk Holding A/S Unveils Key 2025 Financial Dates

Updated Category News Views 494

Nilfisk Holding A/S Financial Calendar for 2025 Nilfisk Holding A/S stands out as a prominent global player in the professional cleaning industry, consistently delivering high-quality products and services. As the new year approaches, the company has set forth significant dates for financial disclosures that are vital for investors and stakeholders alike. Upcoming Key...

Continue Reading
Exciting Return of Twang’s Signature Beer and Pickle Salts

Updated Category News Views 332

Exciting Announcement from Twang Twang, a beloved Latino-founded brand, has once again captured the hearts of flavor enthusiasts. Known for its innovative and enticing blends of flavored salts, Twang is thrilled to share the return of two highly anticipated products: Orange Beer Salt and Hot Pickle Flavored Salt. Fans of these tasty seasonings can look forward to their...

Continue Reading